Summit Securities Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-20
Closed -$325K 383
2020
Q2
$325K Buy
+20
New +$3.58K 0.04% 309
2017
Q3
Sell
-16
Closed -$200K 218
2017
Q2
$200K Buy
+16
New +$1.91K 0.04% 213

Other funds holding CME

Summit Securities Group's CME Position: Q2 2026 in Review

Summit Securities Group reduced its CME Group (CME) stake by 96% in Q2 2026, selling an estimated $546K and leaving 84 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #728.

Summit Securities Group first reported a position in CME in Q2 2013 and has held it in 35 quarters since. The position peaked at $33.4M in Q4 2013. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Summit Securities Group held 84 shares of CME Group worth $18.6K as of Q2 2026.
  • Summit Securities Group sold 1,975 CME Group shares in Q2 2026, an estimated $546K.
  • CME Group made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #728 holding.
  • Summit Securities Group first reported a position in CME Group in Q2 2013 and has held it in 35 quarters since.
  • Summit Securities Group's CME Group position peaked at $33.4M in Q4 2013.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.